Tom Stargardt : Citation Profile


Are you Tom Stargardt?

Universität Hamburg

8

H index

5

i10 index

165

Citations

RESEARCH PRODUCTION:

28

Articles

5

Papers

RESEARCH ACTIVITY:

   13 years (2004 - 2017). See details.
   Cites by year: 12
   Journals where Tom Stargardt has often published
   Relations with other researchers
   Recent citing documents: 42.    Total self citations: 15 (8.33 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pst545
   Updated: 2020-03-21    RAS profile: 2018-09-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Blankart, Katharina (3)

Schreyögg, Jonas (3)

Frey, Simon (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Tom Stargardt.

Is cited by:

Schreyögg, Jonas (15)

Suppliet, Moritz (7)

Herr, Annika (6)

Blankart, Katharina (6)

Eibich, Peter (4)

Ziebarth, Nicolas (4)

Street, Andrew (4)

Vandoros, Sotiris (3)

Miraldo, Marisa (3)

Leidl, Reiner (3)

Mahlich, Jörg (2)

Cites to:

Schreyögg, Jonas (18)

Vandoros, Sotiris (5)

Siciliani, Luigi (4)

Parkin, David (4)

Costa-i-Font, Joan (4)

Grootendorst, Paul (4)

Manning, Willard (4)

Bertrand, Marianne (3)

Mason, Anne (3)

Mullainathan, Sendhil (3)

Wasem, Juergen (3)

Main data


Where Tom Stargardt has published?


Journals with more than one article published# docs
The European Journal of Health Economics8
Health Policy6
Applied Health Economics and Health Policy4
Health Economics4
PharmacoEconomics2
Health Care Management Science2

Working Papers Series with more than one paper published# docs
Discussion Papers / Technische Universitt Berlin, School of Economics and Management2
hche Research Papers / University of Hamburg, Hamburg Center for Health Economics (hche)2

Recent works citing Tom Stargardt (2018 and 2017)


YearTitle of citing document
2020Regulating Innovation with Uncertain Quality: Information, Risk, and Access in Medical Devices. (2020). Town, Robert J ; Grennan, Matthew. In: American Economic Review. RePEc:aea:aecrev:v:110:y:2020:i:1:p:120-61.

Full description at Econpapers || Download paper

2017Supportare la ricerca e l’innovazione in sanità tramite i modelli organizzativi: il caso dell’Azienda Ospedaliera “SS. Antonio e Biagio e Cesare Arrigo” di Alessandria/Supporting research and. (2017). Ippoliti, Roberto ; Maconi, Antonio ; Riva, Franca ; Bertolotti, Marinella ; Falavigna, Greta. In: IRCrES Working Paper. RePEc:csc:ircrwp:201709.

Full description at Econpapers || Download paper

2019The impacts of marketization and subsidies on the treatment quality performance of the Chinese hospitals sector. (2019). He, Xinju ; Ko, Sung. In: China Economic Review. RePEc:eee:chieco:v:54:y:2019:i:c:p:41-50.

Full description at Econpapers || Download paper

2017A review of international coverage and pricing strategies for personalized medicine and orphan drugs. (2017). Degtiar, Irina. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1240-1248.

Full description at Econpapers || Download paper

2017Competition policy for health care provision in Germany. (2017). Kifmann, Mathias. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:2:p:119-125.

Full description at Econpapers || Download paper

2017Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions. (2017). Balasopoulos, T ; Pavi, E ; Kyriopoulos, J ; Athanasakis, K ; Charonis, A. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:3:p:265-272.

Full description at Econpapers || Download paper

2017On the role of environmental corruption in healthcare infrastructures: An empirical assessment for Italy using DEA with truncated regression approach. (2017). Rizzo, Ilde ; Guccio, Calogero ; Cavalieri, Marina. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:5:p:515-524.

Full description at Econpapers || Download paper

2017The bare necessities? A realist review of necessity argumentations used in health care coverage decisions. (2017). Kleinhout-Vliek, Tineke ; Boer, Bert ; de Bont, Antoinette . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:7:p:731-744.

Full description at Econpapers || Download paper

2018The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus. (2018). Torrent-Farnell, J ; Lizan, L ; Urcelay, J ; Cruz, J ; Perez-Lopez, J ; Gutierrez-Solana, L G ; Abaitua, I ; Poveda, J L ; Comellas, M. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:590-598.

Full description at Econpapers || Download paper

2018Confirmatory versus explorative endpoint analysis: Decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs. (2018). Niehaus, Ines ; Dintsios, Charalabos-Markos. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:599-606.

Full description at Econpapers || Download paper

2018Continuity of care and its effect on readmissions for COPD patients: A comparative study of Norway and Germany. (2018). Swanson, Jayson O ; Moger, Tron Anders ; Hagen, Terje P ; Sundmacher, Leonie ; Vogt, Verena . In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:7:p:737-745.

Full description at Econpapers || Download paper

2019Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries. (2019). Kanavos, Panos ; Tinelli, Michela ; Visintin, Erica. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:118-129.

Full description at Econpapers || Download paper

2019Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland. (2019). Sevgur, Serperi ; Gambold, Liesl ; Zieliska, Dorota Anna ; Wranik, Wiesawa Dominika. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:191-202.

Full description at Econpapers || Download paper

2019Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy. (2019). Nuti, Sabina ; Berta, Paolo ; Seghieri, Chiara. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:5:p:449-456.

Full description at Econpapers || Download paper

2018Price competition in pharmaceuticals – Evidence from 1303 Swedish markets. (2018). Granlund, David ; Bergman, Mats A. In: Journal of Health Economics. RePEc:eee:jhecon:v:61:y:2018:i:c:p:1-12.

Full description at Econpapers || Download paper

2019The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. (2019). Wouters, Olivier J ; Kanavos, Panos G ; Pillay, Anban ; Sandberg, Dale M. In: Social Science & Medicine. RePEc:eee:socmed:v:220:y:2019:i:c:p:362-370.

Full description at Econpapers || Download paper

2018The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. (2018). Kanavos, Panos G ; Pillay, Anban ; Sandberg, Dale M ; Wouters, Olivier J. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:90828.

Full description at Econpapers || Download paper

2018Better Spending for Better Lives: How Latin America and the Caribbean Can Do More with Less. (2018). Izquierdo, Alejandro ; Serrano, Rodrigo ; Martinez, Matias ; Elacqua, Gregory ; Pastor, Cinthya ; Vlaicu, Razvan ; Suarez-Aleman, Ancor ; Scartascini, Carlos ; Serebrisky, Tomas ; Keefer, Philip ; Alaimo, Veronica ; Alvarez, Laura Giles ; Riera-Crichton, Daniel ; Cafagna, Gianluca ; Puig, Jorge ; Moreno-Serra, Rodrigo ; Vuletin, Guillermo ; Pinto, Diana M ; Pessino, Carola. In: IDB Publications (Books). RePEc:idb:idbbks:9152.

Full description at Econpapers || Download 2017

Regional regulators in healthcare service under quality competition: A game theoretical model. (2017). Grilli, Luca ; Cellini, Roberto ; Bisceglia, Michele. In: MPRA Paper. RePEc:pra:mprapa:80507.

Full description at Econpapers || Download paper

2018National Health Systems and Healthcare Contracts in the EU: a Review on the Literature over the Last 17 Years. (2018). Stoica, Bogdan ; Bugheanu, Alexandru Mihai . In: Management and Economics Review. RePEc:rom:merase:v:3:y:2018:i:2:p:202-212.

Full description at Econpapers || Download paper

2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

Full description at Econpapers || Download paper

2018Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage. (2018). Maniadakis, Nikolaos ; Wijaya, Kalman ; Gialama, Fotini ; Correa, Jose Otavio ; Holtorf, Anke-Peggy. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:5:d:10.1007_s40258-018-0405-7.

Full description at Econpapers || Download paper

2019Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review. (2019). Wettstein, Dominik J ; Boes, Stefan. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:17:y:2019:i:2:d:10.1007_s40258-018-0437-z.

Full description at Econpapers || Download paper

2017Estimation of a physician practice cost function. (2017). Schreyögg, Jonas ; Schreyogg, Jonas ; Heimeshoff, Mareike ; Kwietniewski, Lukas. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0804-3.

Full description at Econpapers || Download paper

2017Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK. (2017). Weidlich, Diana ; Guest, Julian F ; Jonasson, Aino Fianu ; Drake, Marcus John ; Oelke, Matthias ; Andersson, Fredrik L. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:6:d:10.1007_s10198-016-0826-x.

Full description at Econpapers || Download paper

2018Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Angelis, Aris ; Kanavos, Panos ; Lange, Ansgar . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

Full description at Econpapers || Download paper

2018The impact of physician-level drug budgets on prescribing behavior. (2018). Blankart, Katharina ; Fischer, Katharina Elisabeth ; Stargardt, Tom ; Kostev, Karel ; Koch, Taika . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:2:d:10.1007_s10198-017-0875-9.

Full description at Econpapers || Download paper

2018Introduction of therapeutic reference pricing in Slovenia and its economic consequences. (2018). Maretko, Nika ; Kos, Mitja . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:4:d:10.1007_s10198-017-0903-9.

Full description at Econpapers || Download paper

2018Investigating the relationship between costs and outcomes for English mental health providers: a bi-variate multi-level regression analysis. (2018). Moran, Valerie ; Jacobs, Rowena. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:5:d:10.1007_s10198-017-0915-5.

Full description at Econpapers || Download paper

2017Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare pe. (2017). Hils, Silvia ; Fetzer, Stefan ; Hehn, Philip ; Schmid, Anja ; Hauschke, Dieter ; Bogatyreva, Lioudmila ; Pisarski, Przemyslaw ; Janigen, Bernd ; Kaier, Klaus. In: Health Economics Review. RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-016-0141-3.

Full description at Econpapers || Download 2017

The costs of repatriating an ill seafarer: a micro-costing approach. (2017). Faurby, Mads D ; Andrioti, Despena ; Hjarnoe, Lulu ; Jensen, Olaf C. In: Health Economics Review. RePEc:spr:hecrev:v:7:y:2017:i:1:d:10.1186_s13561-017-0184-0.

Full description at Econpapers || Download paper

2017Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis. (2017). Buchanan, James ; Schuh, Anna ; Taylor, Jenny C ; Robbe, Pauline ; Clifford, Ruth ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0519-z.

Full description at Econpapers || Download paper

2017The Cost of Relapse in Schizophrenia. (2017). Pennington, Mark ; McCrone, Paul . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0515-3.

Full description at Econpapers || Download paper

2018Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany. (2018). Gandjour, Afschin ; Ostwald, Dennis A. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:10:d:10.1007_s40273-018-0688-4.

Full description at Econpapers || Download paper

2018The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian On. (2018). Skedgel, Chris ; Hu, Min ; Wranik, Dominika. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-018-0610-0.

Full description at Econpapers || Download paper

2018New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes. (2018). Varnava, Alice ; Routledge, Philip A ; Hughes, Dyfrig A ; Samuels, Karen ; Bracchi, Robert. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-018-0632-7.

Full description at Econpapers || Download paper

2018Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease. (2018). Walker, Simon ; Richardson, Gerry ; Gale, Chris P ; Bojke, Laura ; Asaria, Miqdad ; Lomas, James. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-018-0068-1.

Full description at Econpapers || Download paper

2017Cui bono? - Die Bürgerversicherung und die Beihilfe. (2017). , Christianhagist ; Hagist, Christian ; Fetzer, Steffen ; Buhrer, Christian. In: WHU Working Paper Series - Economics Group. RePEc:whu:wpaper:17-05.

Full description at Econpapers || Download paper

2017Das Hamburger Beihilfemodell - Ein Vergleich der internen Renditen von GKV und PKV. (2017). , Christianhagist ; Hagist, Christian ; Fetzer, Steffen ; Buhrer, Christian. In: WHU Working Paper Series - Economics Group. RePEc:whu:wpaper:17-06.

Full description at Econpapers || Download paper

2018Adverse Selection in the German Health Insurance System – The Case of Civil Servants. (2018). , Christianhagist ; Hagist, Christian ; Fetzer, Stefan ; Buhrer, Christian. In: WHU Working Paper Series - Economics Group. RePEc:whu:wpaper:18-06.

Full description at Econpapers || Download paper

2017Waiting times for outpatient treatment in Germany: New experimental evidence from primary data. (2017). Wübker, Ansgar ; Wuckel, Christiane ; Wubker, Ansgar ; Heinrich, Nils . In: Ruhr Economic Papers. RePEc:zbw:rwirep:683.

Full description at Econpapers || Download paper

2017Reimbursement Schemes for Hospitals: The Impact of Case and Firm Characteristics. (2017). Wohlschlegel, Ansgar ; Mueller, Helge ; Feess, Eberhard. In: Annual Conference 2016 (Augsburg): Demographic Change. RePEc:zbw:vfsc16:145776.

Full description at Econpapers || Download paper

Works by Tom Stargardt:


YearTitleTypeCited
2012A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data In: Health Policy.
[Full Text][Citation analysis]
article6
2013Reforms in the Greek pharmaceutical market during the financial crisis In: Health Policy.
[Full Text][Citation analysis]
article15
2016Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia In: Health Policy.
[Full Text][Citation analysis]
article5
2016Dispensing behaviour of pharmacies in prescription drug markets In: Health Policy.
[Full Text][Citation analysis]
article0
2016Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—A large population-based cohort study In: Health Policy.
[Full Text][Citation analysis]
article2
2007Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany In: Health Policy.
[Full Text][Citation analysis]
article1
2011Effect of Type of Insurance and Income on Waiting Time for Outpatient Care In: Working Papers.
[Full Text][Citation analysis]
paper10
2012Effect of Type of Insurance and Income on Waiting Time for Outpatient Care.(2012) In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 10
article
2011Effect of type of insurance and income on waiting time for outpatient care.(2011) In: hche Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 10
paper
2017Preferred supplier contracts in post-patent prescription drug markets In: Health Care Management Science.
[Full Text][Citation analysis]
article6
2006Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries In: Health Care Management Science.
[Full Text][Citation analysis]
article28
2012Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2013The Trade-off Between Costs and Quality of Care in the Treatment of Psychosomatic Patients with Somatoform Pain Disorder In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article1
2014Cost-Utility Analysis Comparing Heavy-Weight and Light-Weight Mesh in Laparoscopic Surgery for Unilateral Inguinal Hernias In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2016Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article9
2011Reimbursement of pharmaceuticals: reference pricing versus health technology assessment In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article12
2012Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2016The diffusion of generics after patent expiry in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2017Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2005Defining the “Health Benefit Basket” in nine European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article13
2005Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2011Availability of and Access to Orphan Drugs In: PharmacoEconomics.
[Full Text][Citation analysis]
article4
2016Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2011Modelling pharmaceutical price changes in Germany: a function of competition and regulation In: Applied Economics.
[Full Text][Citation analysis]
article8
2008Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries In: Health Economics.
[Full Text][Citation analysis]
article7
2008Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories In: Health Economics.
[Full Text][Citation analysis]
article7
2011Costs and quality of hospitals in different health care systems: a multi‐level approach with propensity score matching In: Health Economics.
[Full Text][Citation analysis]
article9
2014MEASURING THE RELATIONSHIP BETWEEN COSTS AND OUTCOMES: THE EXAMPLE OF ACUTE MYOCARDIAL INFARCTION IN GERMAN HOSPITALS In: Health Economics.
[Full Text][Citation analysis]
article6
2012Measuring the relationship between costs and outcomes: The example of Acute Myocardial Infarction in German hospitals.(2012) In: hche Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 6
paper
2004Bürgerversicherung: Die Wirkung von Kopfprämien auf den Arbeitsmarkt In: Discussion Papers.
[Full Text][Citation analysis]
paper2
2005Defining benefit catalogues and entitlements to health care in Germany: Decision makers, decision criteria and taxonomy of catalogues In: Discussion Papers.
[Full Text][Citation analysis]
paper1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 4 2020. Contact: CitEc Team